We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Life Sciences/Agaricomycetes mushrooms (Basidiomycota) as potential neuroprotectants
PeriodicalsLife Sciences

Agaricomycetes mushrooms (Basidiomycota) as potential neuroprotectants

Checking your access to this record.

Abstract & Overview

The edible and medicinal agaricoid and polyporoid mushrooms (phylum Basidiomycota, order Agaricomycetes) have long been known by humans as valuable food and medicines. They are producers of different groups of high- and low-molecular weight bioactive compounds (alkaloids, phenolics, polysaccharides, proteins, terpenoids, vitamins etc.) with around 130 therapeutic effects, including neuroprotective. Mushroom-derived biotech products are reported as effective neuroprotectants, however their potential to prevent or mitigate several neurodegenerative pathologies, such as Alzheimer and Parkinson diseases, epilepsy, depression and others has not been fully explored. This review discusses the neuroprotective potential of Agaricomycetes fungi and possibilities for their application as natural neuroprotectants.

Cite this record

Susanna М. Badalyan, Sylvie Rapior (2021). Agaricomycetes mushrooms (Basidiomycota) as potential neuroprotectants. Italian Journal of Mycology. https://doi.org/10.6092/issn.2531-7342/12542

Copy in another style

Badalyan, S. М., & Rapior, S. (2021). Agaricomycetes mushrooms (Basidiomycota) as potential neuroprotectants. Italian Journal of Mycology. https://doi.org/10.6092/issn.2531-7342/12542
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.